Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anand V Kulkarni (Anand Kulkarni, T R Soumya)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 38

Top Venues

Hepatology (Baltimore, Md.)

The American journal of gastroenterology

Hepatology communications

BMJ case reports

Asian Institute of Gastroenterology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Asian Institute of Gastroenterology Dec 1o 2018

India

Assistant professor :: Hepatology

Publications

Govardhan Bale, Anand V Kulkarni, Nagaraja Rao Padaki, P Balachandran Menon, Sundeep Lakhtakia, Sowmya Iyengar, Anuradha Sekaran, Smita C Pawar, Nageshwar Reddy Duvvur, Ravikanth Venkata Vishnubhotla
Comparing rare variants versus common in the pathogenesis of nonalcoholic fatty liver disease: a whole exome sequencing approach. Journal of gastroenterology and hepatology (2023)
Anant Ramaswamy, Anand V Kulkarni, George John, Amit Rauthan, Shekhar Patil, Ajay Kumar Duseja, Vineet Talwar, Senthil J Rajappa, Nikhil Ghadyalpatil, Manav Wadhawan, Akash Shukla, Vamshi M Krishna, Sujay Srinivas, Sunil Taneja, K Mary Sravani, Sahaj Rathi, Prabhat Bhargava, Vikas Ostwal
Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP). JCO global oncology 9 (2023)
Elina En Li Cho, Chong Zhe Ang, Jingxuan Quek, Clarissa Elysia Fu, Lincoln Kai En Lim, Zane En Qi Heng, Darren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, Rebecca Zeng, Douglas Chee, Benjamin Nah, Cosmas Rinaldi Adithya Lesmana, Aung Hlaing Bwa, Khin Maung Win, Claire Faulkner, Majd B Aboona, Mei Chin Lim, Nicholas Syn, Anand V Kulkarni, Hiroyuki Suzuki, Hirokazu Takahashi, Nobuharu Tamaki, Karn Wijarnpreecha, Daniel Q Huang, Mark Dhinesh Muthiah, Cheng-Han Ng, Stephen Caldwell
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut (2023)
Mahathi Avadhanam, Anand V Kulkarni
Conventional Antibiotics for Spontaneous Bacterial Peritonitis: Are They Still Effective? The American journal of gastroenterology (2023)
Anand V Kulkarni, Mahathi Avadhanam, Puja Karandikar, Kalyan Rakam, Anand Gupta, Venu Simhadri, Madhumita Premkumar, Asim Ahmed Zuberi, Deepika Gujjarlapudi, Ramyashri Narendran, Sameer Shaik, Mithun Sharma, Sowmya Tirumalige Ravikumar, Manasa Alla, Shantan Venishetty, Duvvur Nageshwar Reddy, Padaki Nagaraja Rao
Antibiotics with or without Rifaximin for acute hepatic Encephalopathy in critically ill patients with cirrhosis: A double-blind, randomized controlled (ARiE) trial. The American journal of gastroenterology (2023)
Padaki Nagaraja Rao, Anand V Kulkarni
The changing epidemiology of hepatocellular carcinoma! Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2023)
Akash Roy, Ashirwad Pasumarthy, Anand V Kulkarni
Updates in noncirrhotic portal hypertension. Clinical liver disease 22 (2) (2023)
Kamal Kajal, Madhumita Premkumar, Manhal Izzy, Anand V Kulkarni, Ajay Kumar Duseja, Smita Divyaveer, Sekar Loganathan, Bhupendra Sihag, Ankur Gupta, Ajay Bahl, Sahaj Rathi, Sunil Taneja, Arka De, Nipun Verma, Navneet Sharma, Harpreet Kaur, Deepy Zohmangaihi, Vishesh Kumar, Harish Bhujade, Sreedhara B Chaluvashetty, Naveen Kalra
Cirrhotic cardiomyopathy influences clinical outcomes and enhances performance of conventional risk prediction models in acute-on-chronic liver failure with severe sepsis. Alimentary pharmacology & therapeutics (2023)
Swapnali Sabhapandit, Sundeep Lakhtakia, Anand V Kulkarni, Shireesha Anumula, Mounika S Konda, Tumula A Shaik, Perumalla Solomon, Padaki N Rao, Nitin Jagtap, Padaki Nagaraja Rao, Mithun Sharma
Presence of pseudo-Kayser-Fleischer rings in patients without Wilson disease: a prospective cohort study. Hepatology communications 7 (5) (2023)
Anand V Kulkarni, Raghuram Reddy, Mithun Sharma, Sowmya Iyengar, Anuhya Rambhatla, Premkumar Gv, Balachandran Menon, Padaki Nagaraja Rao, Nageshwar Reddy, K Rajender Reddy
Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure. Hepatology international (2023)
Yuzuru Sambommatsu, Charles Mouch, Anand V Kulkarni, David A Bruno, Mehdi Eslami, Daisuke Imai, Seung Duk Lee, Aamir A Khan, Amit Sharma, Muhammad Saeed, Adrian H Cotterell, Marlon F Levy, Megan K Morales, Martin I Montenovo, Padaki N Rao, Raghuram Reddy, Balachandran Menon, Vinay Kumaran
Liver transplantation for post-COVID-19 cholangiopathy: A case series. Clinical transplantation (2023)
Anand V Kulkarni, Sowmya Tirumalige Ravikumar, Harshvardhan Tevethia, Madhumita Premkumar, Karan Kumar, Sundeep Lakhtakia, Rajesh Gupta, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy
Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study. Scientific reports 12 (1) (2022)
Anand V Kulkarni, Sowmya Tirumalle, Madhumita Premkumar, Karan Kumar, Syeda Fatima, Bindu Rapole, Venu Simhadri, Baqar Ali Gora, Mitnala Sasikala, Deepika Gujjarlapudi, Sadhana Yelamanchili, Mithun Sharma, Rajesh Gupta, Padaki Nagaraja Rao, D Nageshwar Reddy
Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial. The American journal of gastroenterology 117 (4) (2022)
Cumali Efe, Anand V Kulkarni, Benedetta Terziroli Beretta Piccoli, Bianca Magro, Albert Stättermayer, Mustafa Cengiz, Daniel I Clayton-Chubb, Craig Steven Lammert, Christine Bernsmeier, Özlem Gül, Fatima Higuera-de la Tijera, Margarita Anders, Ellina Lytvyak, Mete Akın, Tugrul Purnak, Rodrigo Liberal, Mirta Peralta, Berat Ebik, Serkan Duman, Nurhan Demir, H. Yasemin Balaban, Álvaro Urzúa, Fernando Contreras, Maria Grazia Venturelli, Yılmaz Bilgiç, Adriana Medina, Marcos Girala, Fulya Günşar, María Carlota Londoño, Theodoros Androutsakos, Ayelen Kisch, Alper Yurci, Fatih Güzelbulut, Yasir Furkan Çağın, Enver Avcı, Murat Akyıldız, Emine Kübra Dindar-Demiray, Murat Harputluoğlu, Rahul Kumar, Sanjaya Kumar Satapathy, Manuel Mendizabal, Marcelo Silva, Stefano Fagiuoli, Stuart Keith Roberts, Neşe Karadağ Soylu, Ramazan Idilman, Eric M Yoshida, Aldo J Montano-Loza, George N Dalekos, Ezequiel Ridruejo, Thomas D Schiano, Staffan Wahlin
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology (Baltimore, Md.) 76 (6) (2022)
Anand V Kulkarni, Madhumita Premkumar, Duvvur Nageshwar Reddy, Padaki Nagaraja Rao
The challenges of ascites management: An Indian perspective. Clinical liver disease 19 (6) (2022)
Anand V Kulkarni, Pavan Hanchanale, Vikash Prakash, Chetan Kalal, Mithun Sharma, Karan Kumar, Saptarshi Bishnu, Aditya V Kulkarni, Lovkesh Anand, Ajay Kumar Patwa, Sandeep Kumbar, Sumeet Kainth, Cyriac Abby Philips, null null
Tinospora Cordifolia (Giloy)-Induced Liver Injury During the COVID-19 Pandemic-Multicenter Nationwide Study From India. Hepatology communications 6 (6) (2022)
Karan Kumar, Anand V Kulkarni, Vinay K Mahala, Vivek A Saraswat
Early prediction of decompensation in cirrhosis-Is it possible without aetiology and portal hypertension? Liver international : official journal of the International Association for the Study of the Liver 42 (5) (2022)
Anand V Kulkarni, Chandan S Metage, Baqar Ali Gora, Sowmya Tirumalle, Kalyan Rakam, Anveshi Satyavadi, Mithun Sharma, Sameer Shaik, Deepika Gujjarlapudi, Padaki Nagaraja Rao, D Nageshwar Reddy
SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis. Gut (2022)
Harmanpreet Kaur, Radha K Dhiman, Anand V Kulkarni, Madhumita Premkumar, Virendra Singh, Ajay Kumar Duseja, Sandeep Grover, Gagandeep S Grover, Akash Roy, Nipun Verma, Arka De, Sunil Taneja, Rohit Mehtani, Saurabh Mishra, Harpreet Kaur
Improvement of chronic HCV infection-related depression, anxiety, and neurocognitive performance in persons achieving SVR-12: A real-world cohort study. Journal of viral hepatitis 29 (5) (2022)
Anand V Kulkarni, Karan Kumar, Madhumita Premkumar, Padaki Nagaraja Rao, D Nageshwar Reddy
Response to Mir et al. The American journal of gastroenterology 117 (5) (2022)
Anand V Kulkarni, Madhumita Premkumar, Juan Pablo Arab, Karan Kumar, Mithun Sharma, Duvvuru Nageshwar Reddy, Padaki Nagaraja Rao, Rajender K Reddy
Early Diagnosis and Prevention of Infections in Cirrhosis. Seminars in liver disease 42 (3) (2022)
Anand V Kulkarni, Juan Pablo Arab, Madhumita Premkumar, Carlos Benítez, Sowmya Tirumalige Ravikumar, Pramod Kumar, Sundeep Lakhtakia, Duvvuru Nageshwar Reddy, Douglas A Simonetto, Padaki Nagaraja Rao
Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives. Liver international : official journal of the International Association for the Study of the Liver 40 (12) (2021)
Madhumita Premkumar, Rohit Mehtani, Smita Divyaveer, Kamal Kajal, Anand V Kulkarni, Syed Ahmed, Harmanpreet Kaur, Harpreet Kaur, Radhakrishna Dhiman, Ajay Kumar Duseja, Arka De
Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF. Journal of clinical and translational hepatology 9 (2) (2021)
Karan Kumar, Anand V Kulkarni, Rakesh Kumar Jagdish
Letter to the Editor: Saroglitazar for Treatment of NAFLD and NASH. Hepatology (Baltimore, Md.) 74 (6) (2021)
Andrew M Moon, Gwilym J Webb, Ignacio García-Juárez, Anand V Kulkarni, Gupse Adali, David K Wong, Beth Lusina, Georgios N Dalekos, Steven Masson, Brandon M Shore, Eleanor Barnes, Alfred Sidney Barritt, Thomas Marjot
SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination. Hepatology communications (2021)
Karan Kumar, Anand V Kulkarni
Letter to the Editor: Sodium-Glucose Cotransporter-2 Inhibitors Are Not the Magic Pills for Control of Ascites in Cirrhosis and Diabetes. Hepatology (Baltimore, Md.) 73 (2) (2021)
Sundeep Lakhtakia, Anand V Kulkarni, Pramod Kumar, Vijay Bhaskar Nori, Nitin Jagtap, Rajesh Gupta, Duvurr Nageshwar Reddy, Padaki Nagaraja Rao
Author Correction: Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects. Scientific reports 11 (1) (2021)
Anand V Kulkarni, Pramod Kumar, Mithun Sharma, Balachandran Menon, D Nageshwar Reddy, P Nagaraja Rao
Letter to the Editor: Living Donor Liver Transplantation or Deceased Donor Liver Transplantation in High Model for End-Stage Liver Disease Score-Which Is Better? Hepatology (Baltimore, Md.) 73 (6) (2021)
Anand V Kulkarni, Kumarswamy Parthasarathy, Pramod Kumar, Mithun Sharma, Raghuram Reddy, Krishna Chaitanya Akkaraju Venkata, Rajesh Gupta, Anand Gupta, Shakti Swaroop, Premkumar Giri Vishwanathan, Gayathri Senapathy, Palat B Menon, Nageshwar D Reddy, Nagaraja R Padaki
Early liver transplantation after COVID-19 infection: The first report. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21 (6) (2021)
Anand V Kulkarni, Mithun Sharma, Pramod Kumar, Rajesh Gupta, Padaki Nagaraja Rao
Letter to the Editor: Midodrine for Hepatic Hydrothorax. Hepatology (Baltimore, Md.) 73 (3) (2021)
Anand V Kulkarni, Lovkesh Anand, Ashish Kumar Vyas, Madhumita Premkumar, Ashok K Choudhury, Nirupama Trehanpati, Jaya Benjamin, Guresh Kumar, Yogendra Kumar Joshi, Shiv Kumar Sarin
Omega-3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute-on-chronic liver failure: An open-label randomized controlled trial. Journal of gastroenterology and hepatology 36 (7) (2021)
Anand V Kulkarni, Pramod Kumar, Harsh Vardhan Tevethia, Juan Pablo Arab, Roberto Candia, Madhumita Premkumar, Mithun Sharma, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy
Letter: elevated liver enzymes and outcomes in COVID Authors' reply. Alimentary pharmacology & therapeutics 52 (7) (2020)
Anand V Kulkarni, Pramod Kumar, Rupjyoti Talukdar, Nagaraj P Rao
Steroids as rescue therapy for vitamin A-induced acute liver failure. BMJ case reports 13 (3) (2020)
Anand V Kulkarni, Pramod Kumar, Harsh Vardhan Tevethia, Madhumita Premkumar, Juan Pablo Arab, Roberto Candia, Rupjyoti Talukdar, Mithun Sharma, Xiaolong Qi, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Alimentary pharmacology & therapeutics 52 (4) (2020)
Mithun Sharma, Madhumita Premkumar, Anand V Kulkarni, Pramod Kumar, D Nageshwar Reddy, Nagaraja Padaki Rao
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail. Journal of clinical and translational hepatology 9 (1) (2020)
Anand V Kulkarni, Pramod Kumar, Nagaraj P Rao, Nageshwar Reddy
Terlipressin-induced ischaemic skin necrosis. BMJ case reports 13 (1) (2020)
Sundeep Lakhtakia, Anand V Kulkarni, Pramod Kumar, Vijay Bhaskar Nori, Nitin Jagtap, Rajesh Gupta, Duvurr Nageshwar Reddy, Padaki Nagaraja Rao
Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects. Scientific reports 10 (1) (2020)
Anand V Kulkarni, Manoj Kumar Sharma, Kapil Dev Jamwal, Asit Arora
An unusual cause of gastrointestinal bleed in patients with liver cirrhosis. BMJ case reports 12 (7) (2019)

Anand V Kulkarni.css-eqlu8i{font-size:small;padding-left:4px;} (Anand Kulkarni, T R Soumya)

Publication Activity (10 Years)

Top Topics

Top Venues

Anand V Kulkarni (Anand Kulkarni, T R Soumya)